Cargando…
Single cell sequencing reveals cell populations that predict primary resistance to imatinib in chronic myeloid leukemia
The treatment of chronic myeloid leukemia (CML), a disease caused by t(9;22)(q34;q11) reciprocal translocation, has advanced largely through the use of targeted tyrosine kinase inhibitors (TKIs). To identify molecular differences that might distinguish TKI responders from non-responders, we performe...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7803567/ https://www.ncbi.nlm.nih.gov/pubmed/33226961 http://dx.doi.org/10.18632/aging.104136 |
_version_ | 1783635967822790656 |
---|---|
author | Zhang, Weilong Yang, Beibei Weng, Linqian Li, Jiangtao Bai, Jiefei Wang, Ting Wang, Jingwen Ye, Jin Jing, Hongmei Jiao, Yuchen Chen, Xixi Liu, Hui Zeng, Yi-Xin |
author_facet | Zhang, Weilong Yang, Beibei Weng, Linqian Li, Jiangtao Bai, Jiefei Wang, Ting Wang, Jingwen Ye, Jin Jing, Hongmei Jiao, Yuchen Chen, Xixi Liu, Hui Zeng, Yi-Xin |
author_sort | Zhang, Weilong |
collection | PubMed |
description | The treatment of chronic myeloid leukemia (CML), a disease caused by t(9;22)(q34;q11) reciprocal translocation, has advanced largely through the use of targeted tyrosine kinase inhibitors (TKIs). To identify molecular differences that might distinguish TKI responders from non-responders, we performed single cell RNA sequencing on cells (n = 41,723 cells) obtained from the peripheral blood of four CML patients at different stages of treatment to generate single cell expression profiles. Analysis of our single cell expression profiles in conjunction with those previously obtained from the bone marrow of additional CML patients and healthy donors (total = 69,263 cells) demonstrated that imatinib treatment significantly altered leukocyte population compositions in both responders and non-responders, and affected the expression profiles of multiple cell populations, including non-neoplastic cell types. Notably, in imatinib poor-responders, patient-specific pre-treatment unique stem/progenitor cells became enriched in peripheral blood compared to the responders. These results indicate that resistance to TKIs might be intrinsic in some CML patients rather than acquired, and that non-neoplastic immune cell types may also play vital roles in dispersing the responsiveness of patients to TKIs. Furthermore, these results demonstrated the potential utility of peripheral blood as a diagnostic tool in the TKI sensitivity of CML patients. |
format | Online Article Text |
id | pubmed-7803567 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Impact Journals |
record_format | MEDLINE/PubMed |
spelling | pubmed-78035672021-01-15 Single cell sequencing reveals cell populations that predict primary resistance to imatinib in chronic myeloid leukemia Zhang, Weilong Yang, Beibei Weng, Linqian Li, Jiangtao Bai, Jiefei Wang, Ting Wang, Jingwen Ye, Jin Jing, Hongmei Jiao, Yuchen Chen, Xixi Liu, Hui Zeng, Yi-Xin Aging (Albany NY) Research Paper The treatment of chronic myeloid leukemia (CML), a disease caused by t(9;22)(q34;q11) reciprocal translocation, has advanced largely through the use of targeted tyrosine kinase inhibitors (TKIs). To identify molecular differences that might distinguish TKI responders from non-responders, we performed single cell RNA sequencing on cells (n = 41,723 cells) obtained from the peripheral blood of four CML patients at different stages of treatment to generate single cell expression profiles. Analysis of our single cell expression profiles in conjunction with those previously obtained from the bone marrow of additional CML patients and healthy donors (total = 69,263 cells) demonstrated that imatinib treatment significantly altered leukocyte population compositions in both responders and non-responders, and affected the expression profiles of multiple cell populations, including non-neoplastic cell types. Notably, in imatinib poor-responders, patient-specific pre-treatment unique stem/progenitor cells became enriched in peripheral blood compared to the responders. These results indicate that resistance to TKIs might be intrinsic in some CML patients rather than acquired, and that non-neoplastic immune cell types may also play vital roles in dispersing the responsiveness of patients to TKIs. Furthermore, these results demonstrated the potential utility of peripheral blood as a diagnostic tool in the TKI sensitivity of CML patients. Impact Journals 2020-11-23 /pmc/articles/PMC7803567/ /pubmed/33226961 http://dx.doi.org/10.18632/aging.104136 Text en Copyright: © 2020 Zhang et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/3.0/) (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Paper Zhang, Weilong Yang, Beibei Weng, Linqian Li, Jiangtao Bai, Jiefei Wang, Ting Wang, Jingwen Ye, Jin Jing, Hongmei Jiao, Yuchen Chen, Xixi Liu, Hui Zeng, Yi-Xin Single cell sequencing reveals cell populations that predict primary resistance to imatinib in chronic myeloid leukemia |
title | Single cell sequencing reveals cell populations that predict primary resistance to imatinib in chronic myeloid leukemia |
title_full | Single cell sequencing reveals cell populations that predict primary resistance to imatinib in chronic myeloid leukemia |
title_fullStr | Single cell sequencing reveals cell populations that predict primary resistance to imatinib in chronic myeloid leukemia |
title_full_unstemmed | Single cell sequencing reveals cell populations that predict primary resistance to imatinib in chronic myeloid leukemia |
title_short | Single cell sequencing reveals cell populations that predict primary resistance to imatinib in chronic myeloid leukemia |
title_sort | single cell sequencing reveals cell populations that predict primary resistance to imatinib in chronic myeloid leukemia |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7803567/ https://www.ncbi.nlm.nih.gov/pubmed/33226961 http://dx.doi.org/10.18632/aging.104136 |
work_keys_str_mv | AT zhangweilong singlecellsequencingrevealscellpopulationsthatpredictprimaryresistancetoimatinibinchronicmyeloidleukemia AT yangbeibei singlecellsequencingrevealscellpopulationsthatpredictprimaryresistancetoimatinibinchronicmyeloidleukemia AT wenglinqian singlecellsequencingrevealscellpopulationsthatpredictprimaryresistancetoimatinibinchronicmyeloidleukemia AT lijiangtao singlecellsequencingrevealscellpopulationsthatpredictprimaryresistancetoimatinibinchronicmyeloidleukemia AT baijiefei singlecellsequencingrevealscellpopulationsthatpredictprimaryresistancetoimatinibinchronicmyeloidleukemia AT wangting singlecellsequencingrevealscellpopulationsthatpredictprimaryresistancetoimatinibinchronicmyeloidleukemia AT wangjingwen singlecellsequencingrevealscellpopulationsthatpredictprimaryresistancetoimatinibinchronicmyeloidleukemia AT yejin singlecellsequencingrevealscellpopulationsthatpredictprimaryresistancetoimatinibinchronicmyeloidleukemia AT jinghongmei singlecellsequencingrevealscellpopulationsthatpredictprimaryresistancetoimatinibinchronicmyeloidleukemia AT jiaoyuchen singlecellsequencingrevealscellpopulationsthatpredictprimaryresistancetoimatinibinchronicmyeloidleukemia AT chenxixi singlecellsequencingrevealscellpopulationsthatpredictprimaryresistancetoimatinibinchronicmyeloidleukemia AT liuhui singlecellsequencingrevealscellpopulationsthatpredictprimaryresistancetoimatinibinchronicmyeloidleukemia AT zengyixin singlecellsequencingrevealscellpopulationsthatpredictprimaryresistancetoimatinibinchronicmyeloidleukemia |